(NASDAQ: SYBX) Synlogic's forecast annual revenue growth rate of 89.51% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.36%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.64%.
Synlogic's revenue in 2024 is $3,205,000.On average, 1 Wall Street analysts forecast SYBX's revenue for 2024 to be $9,248,539, with the lowest SYBX revenue forecast at $9,248,539, and the highest SYBX revenue forecast at $9,248,539. On average, 1 Wall Street analysts forecast SYBX's revenue for 2025 to be $104,894,819, with the lowest SYBX revenue forecast at $104,894,819, and the highest SYBX revenue forecast at $104,894,819.
In 2026, SYBX is forecast to generate $266,334,500 in revenue, with the lowest revenue forecast at $266,334,500 and the highest revenue forecast at $266,334,500.